Cancer-TargetingCompound1可用于与激素相关的癌症研究，摘自专利WO2008021331A2。
CAS：1007581-62-5
分子式：C15H13N3O2S
分子量：299.35
纯度：98%
存储：Store at -20°C

Background:

Cancer-Targeting Compound 1 is used in the research of hormone-?related cancer, extracted from patent WO 2008021331 A2.

Cancer-Targeting Compound 1 is useful for the research of hormone-related conditions including contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake or synchronizing estrus[1].

[1]. Thomas, Joseph, et al. OXAZOLIDONE DERIVATIVES AS PR MODULATORS. WO 2008021331 A2.